2003
DOI: 10.1074/jbc.m211407200
|View full text |Cite
|
Sign up to set email alerts
|

A Cortactin-CD2-associated Protein (CD2AP) Complex Provides a Novel Link between Epidermal Growth Factor Receptor Endocytosis and the Actin Cytoskeleton

Abstract: Growth factor regulation of the cortical actin cytoskeleton is fundamental to a wide variety of cellular processes. The cortical actin-associated protein, cortactin, regulates the formation of dynamic actin networks via the actin-related protein (Arp)2/3 complex and hence is a key mediator of such responses. In order to reveal novel roles for this versatile protein, we used a proteomics-based approach to isolate cortactin-interacting proteins. This identified several proteins, including CD2-associated protein … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

4
194
1
2

Year Published

2004
2004
2016
2016

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 203 publications
(201 citation statements)
references
References 43 publications
4
194
1
2
Order By: Relevance
“…Nephrin , a member of the Ig-superfamily (Ig-SF) of transmembrane cell adhesion molecules, is one of the major structural components of the slit diaphragm [15]. The cytoplasmic tail of nephrin, like other transmembrane Ig-SF members, is anchored to the actin cytoskeleton of podocyte by means of CD2-associated protein, CD2AP , a cytoplasmic adaptor protein which interacts with actin [16] and the actin-binding proteins cortactin [17], capping protein Z (CapZ) [18], and the actin polymerization complex Arp2/3 [17]. CD2AP and nephrin interact with the p85 regulatory subunit of phosphoinositide 3-OH kinase (PI3K), recruit PI3K to the plasma membrane, and stimulate PI3K-dependent AKT signaling in podocytes [19], thus participating in a common signaling pathway necessary to maintain crucial podocyte functions.…”
Section: The Podocyte’s Strength and Weakness: Its Actin Cytoskeletonmentioning
confidence: 99%
“…Nephrin , a member of the Ig-superfamily (Ig-SF) of transmembrane cell adhesion molecules, is one of the major structural components of the slit diaphragm [15]. The cytoplasmic tail of nephrin, like other transmembrane Ig-SF members, is anchored to the actin cytoskeleton of podocyte by means of CD2-associated protein, CD2AP , a cytoplasmic adaptor protein which interacts with actin [16] and the actin-binding proteins cortactin [17], capping protein Z (CapZ) [18], and the actin polymerization complex Arp2/3 [17]. CD2AP and nephrin interact with the p85 regulatory subunit of phosphoinositide 3-OH kinase (PI3K), recruit PI3K to the plasma membrane, and stimulate PI3K-dependent AKT signaling in podocytes [19], thus participating in a common signaling pathway necessary to maintain crucial podocyte functions.…”
Section: The Podocyte’s Strength and Weakness: Its Actin Cytoskeletonmentioning
confidence: 99%
“…A growing list of cortactin-binding partners has been identified, including proteins that regulate receptor clustering, endocytosis, and vesicle transport such as dynamin 2 (McNiven et al, 2000) and CD2AP (CIN85-related protein) (Lynch et al, 2003). Recent results from studies in cultured cells (Lynch et al, 2003;Timpson et al, 2005) indicate that cortactin could participate in receptor-mediated endocytosis of the epidermal growth factor (EGF) receptor (EGFR).…”
mentioning
confidence: 99%
“…Recent results from studies in cultured cells (Lynch et al, 2003;Timpson et al, 2005) indicate that cortactin could participate in receptor-mediated endocytosis of the epidermal growth factor (EGF) receptor (EGFR). Thus, cortactin overexpression attenuated ligand-induced downregulation of EGFR and led to sustained activation of EGFR signalling.…”
mentioning
confidence: 99%
“…In trafficking events, cortactin has been involved in clathrin-mediated endocyto-sis as well as in pinocytosis, regulation of epidermal growth factor receptor (EGFR) degradation, or endosomal positioning (McNiven et al, 2000;Cao et al, 2003Cao et al, , 2005Lynch et al, 2003;Cabezas et al, 2005;Merrifield et al, 2005;Sauvonnet et al, 2005;Timpson et al, 2005;Zhu et al, 2005;Mettlen et al, 2006;Le Clainche et al, 2007).…”
Section: Introductionmentioning
confidence: 99%